Identification of a Polypeptide Inhibitor of O‑GlcNAc Transferase with Picomolar Affinity

• Published in: Journal of the American Chemical Society 2024-09, Vol.146 (38), p.26320-26330
• Main Authors: Hammel, Forrest A., Payne, N. Connor, Marando, Victoria M., Mazitschek, Ralph, Walker, Suzanne
• Format: Article
• Language: English
• Subjects: Enzyme Inhibitors - chemistry; Enzyme Inhibitors - metabolism; Enzyme Inhibitors - pharmacology; Fluorescence Resonance Energy Transfer; Host Cell Factor C1 - antagonists & inhibitors; Host Cell Factor C1 - chemistry; Host Cell Factor C1 - metabolism; Humans; Models, Molecular; N-Acetylglucosaminyltransferases - antagonists & inhibitors; N-Acetylglucosaminyltransferases - chemistry; N-Acetylglucosaminyltransferases - metabolism; Peptides - chemistry; Peptides - metabolism; Peptides - pharmacology
• ISSN: 0002-7863; 1520-5126; 1520-5126
• DOI: 10.1021/jacs.4c08656

O-GlcNAc transferase (OGT) is an essential mammalian enzyme that binds thousands of different proteins, including substrates that it glycosylates and nonsubstrate interactors that regulate its biology. OGT also has one proteolytic substrate, the transcriptional coregulator host cell factor 1 (HCF-1), which it cleaves in a process initiated by glutamate side chain glycosylation at a series of central repeats. Although HCF-1 is OGT’s most prominent binding partner, its affinity for the enzyme has not been quantified. Here, we report a time-resolved Förster resonance energy transfer assay to measure ligand binding to OGT and show that an HCF-1-derived polypeptide (HCF3R) binds with picomolar affinity to the enzyme (K D ≤ 85 pM). This high affinity is driven in large part by conserved asparagines in OGT’s tetratricopeptide repeat domain, which form bidentate contacts to the HCF-1 peptide backbone; replacing any one of these asparagines with alanine reduces binding by more than 5 orders of magnitude. Because the HCF-1 polypeptide binds so tightly to OGT, we tested its ability to inhibit enzymatic function. We found that HCF3R potently inhibits OGT both in vitro and in cells and used this finding to develop a genetically encoded, inducible OGT inhibitor that can be degraded with a small molecule, allowing for reversible and tunable inhibition of OGT.